• 3 reasons pharmacist pay fell 5% last year

    Despite tackling more responsibilities during the COVID-19 pandemic, pharmacists saw their inflation-adjusted pay drop by about 5 percent last year, according to a recent The New York Times report.
  • Jaguar Health gets 180 days to comply with Nasdaq bid rule

    Pharmaceutical company Jaguar Health has been granted until Feb. 13, 2023, to comply with Nasdaq's $1 bid price requirement, the company said Aug. 19.
  • Penn Highlands acquires 9th pharmacy

    A ninth retail pharmacy has been acquired by DuBois, Pa.-based Penn Highlands Healthcare, The Bradford Era reported Aug. 19.
  • Frustrated with drug prices, some pharmacies bypass insurance

    A small but growing number of pharmacies are opting to bypass the nation's health insurance system and sell generic drugs straight to consumers at lower prices, NBC News reported Aug. 19.
  • Community pharmacies face Adderall supply disruptions

    Many community pharmacists are struggling to stock Adderall amid supply disruptions and high demand for the attention-deficit/hyperactivity disorder treatment, Bloomberg reported Aug. 18. 
  • With mountain of opioid lawsuits, Endo files for bankruptcy

    Endo International, an Ireland and Malvern, Pa.-based pharmaceutical company, filed for bankruptcy Aug. 16 as it shoulders about 31,000 lawsuits accusing the company of fueling the opioid crisis, according to The Wall Street Journal. 
  • Omicron-tweaked vaccines could be for everyone 12 and up, White House says

    The updated COVID-19 boosters aimed at targeting omicron subvariants BA.4 and BA.5 could soon be authorized for people 12 and older, White House COVID-19 response coordinator Ashish Jha, MD, told NBC News Aug. 17.
  • Pharma giants slam Medicare drug price negotiation

    The Inflation Reduction Act of 2022 opens the door for Medicare to negotiate prices for certain drugs — a change that drug manufacturers strongly oppose. 
  • Fed up with reduced hours, staffing shortages, customers shift to local pharmacies

    As Walgreens is offering bonuses up to $75,000 to recruit pharmacists and workforce shortages are hindering pharmacy services, such as prescribing COVID-19 antiviral drugs, some local pharmacies may soon see more customers. 
  • Digital pharmacy Medly lays off 16% of staff

    Medly Pharmacy has let go of 16 percent of its workforce, the digital pharmacy's chief executive wrote in a recent LinkedIn post.
  • Sanofi scraps breast cancer drug candidate

    Global drugmaker Sanofi is dropping its treatment intended for breast cancer after a phase 3 trial with other drugs failed to meet progression-free survival goals. 
  • 10 systems seeking pharmacy leaders

    The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week.
  • Moderna taps new CFO

    Vaccine-maker Moderna appointed James Mock to become the Cambridge, Mass-based company's CFO starting Sept. 6. 
  • J&J business argues bankruptcy is only option in talc lawsuits

    A subsidiary of pharmaceutical company Johnson & Johnson, LTL Management, said in court documents that bankruptcy is the only option to settle the thousands of lawsuits lodged against J&J's talc-based baby powder, The Wall Street Journal reported Aug. 16. 
  • FDA hits Emergent BioSolutions facility with 'significant violations'

    In a volley between the FDA and Emergent BioSolutions over the biotech's Baltimore facility, the agency said Emergent was "inadequate" in its efforts to fix drug manufacturing errors. 
  • Novavax eyes COVID-19 booster authorization from FDA

    Novavax, a pharmaceutical company that recently gained the FDA's emergency use authorization for its COVID-19 vaccine, is now pushing for its booster candidate to be authorized for adults.
  • Merck pays $150M in partnership with biotech company

    Pharmaceutical company Merck is partnering with biotechnology company Orna Therapeutics to develop treatments in oncology and infectious diseases; Merck will pay $150 million upfront to Orna.
  • Century-old tuberculosis vaccine may protect against COVID-19, study finds

    A tuberculosis vaccine that's 100 years old and costs less than a dollar per dose could have a shot at preventing COVID-19 infections, according to researchers from Boston's Massachusetts General Hospital.
  • Pfizer's antiviral drug could result in 'Paxlovid mouth'

    Paxlovid, Pfizer's popular antiviral drug treatment, is leaving a sour taste in people's mouths, The Wall Street Journal reported Aug. 16.
  • How the dismissal of Roe affects pregnancy products

    After Roe v. Wade was overturned in June, access to some drugs and pharmacy products related to pregnancy, such as condoms, has been strained, and some pharmacies are scrambling to provide healthcare without breaking laws.

Featured Whitepapers

Featured Webinars